Your browser doesn't support javascript.
loading
Platelet rich plasma for facial rejuvenation: an overview of systematic reviews.
Cruciani, Mario; Masiello, Francesca; Pati, Ilaria; Pupella, Simonetta; De Angelis, Vincenzo.
Afiliación
  • Cruciani M; National Blood Centre, Italian National Institute of Health, Rome, Italy.
  • Masiello F; National Blood Centre, Italian National Institute of Health, Rome, Italy.
  • Pati I; National Blood Centre, Italian National Institute of Health, Rome, Italy.
  • Pupella S; National Blood Centre, Italian National Institute of Health, Rome, Italy.
  • De Angelis V; National Blood Centre, Italian National Institute of Health, Rome, Italy.
Blood Transfus ; 2024 Feb 21.
Article en En | MEDLINE | ID: mdl-38557322
ABSTRACT

BACKGROUND:

Platelet-rich plasma (PRP) as a non-surgical therapy for facial rejuvenation is increasingly adopted. This article aims to review the literature and critically appraise the available evidence regarding the efficacy and safety of PRP for facial rejuvenation. MATERIAL AND

METHODS:

An overview of systematic reviews (SRs) of PRP use for facial rejuvenation. The methodological quality of the SRs was assessed using the AMSTAR-2 checklist; quality of the evidence from the trials included in each SR was appraised following the GRADE approach.

RESULTS:

Thirteen SRs published between 2015 and 2023, reporting data from 114 overlapping reports, based on 28 individual primary studies (18 uncontrolled reports), were included in this umbrella review. Eight primary studies evaluated PRP in combination with other treatments (laser therapy, fat grafting, hyaluronic acid, basic fibroblast growth factor), and 20 PRP monotherapy. Most of the included primary studies were uncontrolled, and meta-analysis for outcomes related to facial rejuvenation was conducted in only 1 of the 13 SRs, showing that patients treated with PRP as an adjunct treatment have increased satisfaction over controls without PRP (mean difference, 0.63; 95% confidence intervals (CIs) 0.25/1; p=0-001; low certainty of evidence due to risk of bias (ROB) and inconsistency). No other quantitative data were available from the SRs, although 4 SRs concluded in a descriptive way reveal that PRP combined with laser therapy increased subject satisfaction and skin elasticity, and decreased the erythema index (very low certainty of evidence due to imprecision, unsystematic clinical observations, and ROB). The occurrence of adverse events was a predefined outcome in only 2 SRs (15%). Almost all the SRs demonstrated poor compliance with the AMSTAR 2 items, and the confidence in the results of SRs was graded as low or critically low in 12 of the 13 SRs.

DISCUSSION:

The available evidence is insufficient to suggest firm conclusions about the use of PRP, alone or in combination with other treatments, in promoting facial rejuvenation.

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Blood Transfus Año: 2024 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Blood Transfus Año: 2024 Tipo del documento: Article País de afiliación: Italia